Comerica Securities’s Veracyte VCYT Stock Holding History

Comerica Securities’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10	Closed	-$237	–	1377
2022 Q4	$237	Buy	+10	New	+$232	﹤0.01%	1475

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Comerica Securities's VCYT Position: Q1 2023 in Review

Comerica Securities sold out of Veracyte (VCYT) in Q1 2023, closing a stake of 10 shares — an estimated $237 sold.

Comerica Securities first reported a position in VCYT in Q4 2022 and held it in 1 quarter. The position peaked at $237 in Q4 2022. 232 funds tracked by Wall St. Rank hold VCYT as of Q1 2023.

Comerica Securities reported no remaining Veracyte position as of Q1 2023 after selling out during the quarter.
Comerica Securities sold 10 Veracyte shares in Q1 2023, an estimated $237.
Comerica Securities first reported a position in Veracyte in Q4 2022 and held it in 1 quarter.
Comerica Securities's Veracyte position peaked at $237 in Q4 2022.
232 funds tracked by Wall St. Rank held Veracyte as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.